首页> 外文期刊>Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences >Development and validation of HPLC method for simultaneous estimation of piperine and guggulsterones in compound Unani formulation (tablets) and a nanoreservoir system
【24h】

Development and validation of HPLC method for simultaneous estimation of piperine and guggulsterones in compound Unani formulation (tablets) and a nanoreservoir system

机译:HPLC方法的开发和验证,该方法可同时估算复方Unani制剂(片剂)中的胡椒碱和古格列酮和一种纳米储库系统

获取原文
获取原文并翻译 | 示例
           

摘要

An attempt has been made to develop and validate a simultaneous HPLC method for novel approach of drug release via oil-in-water (o/w) nanoemulsion formulation and Habb-e-Khardal Unani tablet containing piperine and guggul sterones E and Z as main ingredients. Nanoemulsion was prepared by titration method using sefsol-218 as an oily phase, cremophor-EL as a surfactant, transcutol as a co-surfactant and distilled water as an aqueous phase. The formulation was optimized on the basis of thermodynamic stability and dispersibilty test. The nanoformulation was evaluated for particle size, surface morphology, electrical conductivity and viscosity determination. The in vitro dissolution was carried out by dialysis bag method. Drugs were quantified using an HPLC method developed in-house with a C 18 column as stationary phase and acetonitrile and water as mobile phase at λ max of 240nm. The optimized formulation showed higher drug release, lower droplet size and less viscosity as compared with the conventional Habb-e-Khardal Unani tablet. The present study illustrated the potential of nanoemulsion dosage form in improving biopharmaceutic performance of piperine and guggul sterone. The HPLC method was also found to be quite sufficient for the routine quality control of formulations containing piperine and guggul sterone E and Z as ingredients and also for in vitro drug release studies.
机译:已经尝试开发和验证同时HPLC方法用于通过水包油(o / w)纳米乳剂配方和以胡椒碱和琼脂固醇E和Z为主要成分的Habb-e-Khardal Unani片剂释放药物的新方法配料。通过滴定法使用sefsol-218作为油相,cremophor-EL作为表面活性剂,transcutol作为助表面活性剂以及蒸馏水作为水相来制备纳米乳液。根据热力学稳定性和分散性测试对配方进行了优化。评价纳米制剂的粒度,表面形态,电导率和粘度测定。通过透析袋法进行体外溶出。使用内部开发的HPLC方法对药物进行定量,其中C 18色谱柱作为固定相,乙腈和水作为流动相,λmax为240nm。与常规的Habb-e-Khardal Unani片剂相比,优化的制剂显示出更高的药物释放,更低的液滴尺寸和更低的粘度。本研究说明了纳米乳液剂型在改善胡椒碱和琼脂的固醇生物药物性能方面的潜力。还发现,HPLC方法对于含胡椒碱和富勒烯固酮E和Z作为成分的制剂的常规质量控制以及体外药物释放研究已经足够。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号